Wall Street analyst estimates for Stereotaxis, Inc. (STXS): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-10 | $-0.05 | ||
| 2026-08-11 | $-0.05 | $-0.05 | +0.0% |
| 2026-05-12 | $-0.03 | $-0.04 | +25.0% |
| 2026-03-09 | $-0.06 | $-0.06 | +0.0% |
| 2025-11-11 | $-0.03 | $-0.06 | +50.0% |
| 2025-08-07 | $-0.05 | $-0.07 | +28.6% |
| 2025-05-12 | $-0.07 | $-0.07 | +0.0% |
| 2025-03-03 | $-0.09 | $-0.06 | -50.0% |
Valuation Ratios
| Price / Book | 7.04 |
| EV / EBITDA | -5.77 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.2M | $31.1M | $29.3M | $28.9M | $26.6M | $35.0M | $28.1M | $26.8M | $26.9M | $32.4M |
| Cost of Revenue | $7.5M | $10.8M | $5.7M | $6.1M | $7.7M | $11.8M | $9.7M | $11.9M | $12.3M | $15.3M |
| Gross Profit | $24.6M | $20.4M | $23.6M | $22.8M | $19.0M | $23.2M | $18.5M | $14.9M | $14.6M | $17.1M |
| Research & Development | $5.5M | $4.8M | $8.2M | $9.0M | $8.1M | $10.2M | $10.6M | $10.3M | $9.8M | $9.4M |
| Selling, General & Admin | $25.6M | $21.5M | $17.9M | $18.6M | $17.5M | $25.9M | $26.7M | $26.4M | $29.6M | $30.3M |
| Operating Expenses | $31.1M | $26.3M | $26.1M | $27.6M | $25.7M | $36.1M | $37.2M | $36.7M | $39.3M | $39.2M |
| Operating Income | -$6.4M | -$5.9M | -$2.5M | -$4.8M | -$6.7M | -$12.9M | -$18.8M | -$21.8M | -$24.7M | -$22.1M |
| EBITDA | -$5.9M | -$5.1M | -$1.8M | -$4.7M | -$6.6M | -$10.6M | -$17.9M | -$20.1M | -$23.1M | -$20.1M |
| Interest Expense | $2.5M | $179844 | $16566 | 0 | 0 | $10071 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -$5.3M | -$5.9M | $116756 | -$4.6M | -$6.6M | -$10.7M | -$18.3M | -$20.7M | -$24.0M | -$21.6M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$5.3M | -$5.9M | $116756 | -$4.6M | -$6.6M | -$10.7M | -$18.3M | -$20.7M | -$24.0M | -$21.6M |
| EPS | $-0.24 | $-0.26 | $0.00 | $-0.07 | $-0.11 | $-0.16 | $-0.26 | $-0.27 | $-0.30 | $-0.25 |
| EPS (Diluted) | $-0.24 | $-0.26 | $0.00 | $-0.07 | $-0.11 | $-0.16 | $-0.26 | $-0.27 | $-0.30 | $-0.25 |
| Shares Outstanding (Diluted) | $21.8M | $22.6M | $52.1M | $63.1M | $72.7M | $75.6M | $76.1M | $80.7M | $85.2M | $91.0M |
Price
| Price | $1.32 |
| Market Cap | $129M |
| Exchange | AMEX |
| Country | US |
Related companies: ARCT · CVRX · HUMA · MDXH · NEO · OSUR · QTRX
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of STXS: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks